Literature DB >> 14624931

Hormonal and morphologic evaluation of the effects of antiandrogens on the blood supply of the rat prostate.

Yasuhiro Shibata1, Yoshihiro Ono, Bunzo Kashiwagi, Kazuhiro Suzuki, Yoshitatsu Fukabori, Seijiro Honma, Hidetoshi Yamanaka.   

Abstract

OBJECTIVES: To clarify the basic aspects of the regulation of the prostatic blood supply by antiandrogens, their effect on the prostatic blood supply was studied for both androgen content and morphology of true capillaries in the rat ventral prostate. The effectiveness of antiandrogens on the control of hemorrhagic status in prostatic diseases has been previously reported.
METHODS: Androgen concentrations in the prostate were quantified after administration of chlormadinone acetate (CMA), finasteride, or flutamide. The prostatic blood supplies were measured after administration of CMA, finasteride, flutamide, or bicalutamide. The alpha-blockers, terazosin and tamsulosin, were included in the study as negative controls. The histologic changes in the capillaries of the ventral prostate were observed, and the luminal area was measured.
RESULTS: The prostate dihydrotestosterone concentrations were decreased by the administration of all antiandrogens. Treatment with CMA, finasteride, flutamide, or bicalutamide reduced the prostatic blood supply by 50% to 65%. The parallel reduction in luminal areas of the true capillaries was observed in rats treated with CMA. Treatment with alpha-blockers did not affect the prostate androgen content, prostatic blood supply, or capillary luminal area.
CONCLUSIONS: The reduction of the prostatic blood supply was suggested to be the result of a decrease in dihydrotestosterone content and the reduction in the luminal area of capillaries. The early reductive effect of antiandrogens on the prostatic blood supply suggests an alternative use for antiandrogens independent of their typical use for prostate volume regression. The results support the basic aspects of the advantage of preoperative treatment with CMA, flutamide, and bicalutamide, similar to finasteride, in reducing perioperative hemorrhage.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14624931     DOI: 10.1016/s0090-4295(03)00566-1

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  4 in total

1.  Androgen withdrawal fails to induce detectable tissue hypoxia in the rat prostate.

Authors:  Sietze Regter; Mohammad Hedayati; Yonggang Zhang; Haoming Zhou; Susan Dalrymple; Cameron J Koch; John T Isaacs; Theodore L DeWeese
Journal:  Prostate       Date:  2014-03-27       Impact factor: 4.104

2.  Effects of finasteride on the vascular surface density, number of microvessels and vascular endothelial growth factor expression of the rat prostate.

Authors:  A Erdem Canda; M Ugur Mungan; Osman Yilmaz; Kutsal Yorukoglu; Emre Tuzel; Ziya Kirkali
Journal:  Int Urol Nephrol       Date:  2006       Impact factor: 2.370

3.  Multimodal imaging guided preclinical trials of vascular targeting in prostate cancer.

Authors:  James Kalmuk; Margaret Folaron; Julian Buchinger; Roberto Pili; Mukund Seshadri
Journal:  Oncotarget       Date:  2015-09-15

4.  REST reduction is essential for hypoxia-induced neuroendocrine differentiation of prostate cancer cells by activating autophagy signaling.

Authors:  Tzu-Ping Lin; Yi-Ting Chang; Sung-Yuan Lee; Mel Campbell; Tien-Chiao Wang; Shu-Huei Shen; Hsiao-Jen Chung; Yen-Hwa Chang; Allen W Chiu; Chin-Chen Pan; Chi-Hung Lin; Cheng-Ying Chu; Hsing-Jien Kung; Chia-Yang Cheng; Pei-Ching Chang
Journal:  Oncotarget       Date:  2016-05-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.